I Cass

Summary

Affiliation: Cedars-Sinai Medical Center
Country: USA

Publications

  1. ncbi request reprint Improved survival in women with BRCA-associated ovarian carcinoma
    Ilana Cass
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cedars Sinai Medical Center and University of California Los Angeles School of Medicine, Los Angeles, California 90048, USAA
    Cancer 97:2187-95. 2003
  2. ncbi request reprint Effect of obesity on survival in epithelial ovarian cancer
    James C Pavelka
    Cedars Sinai Medical Center, Women s Cancer Research Institute at the Samuel Oschin Comprehensive Cancer Institute, Los Angeles, California, USA
    Cancer 107:1520-4. 2006
  3. ncbi request reprint Tertiary cytoreductive surgery in recurrent ovarian cancer: selection criteria and survival outcome
    Amer K Karam
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Cedars Sinai Medical Center, 8700 Beverly Blvd, Los Angeles, CA 90048, USA
    Gynecol Oncol 104:377-80. 2007
  4. ncbi request reprint Lessons learned in physician reentry
    Ilana Cass
    Department Obstetrics and Gynecology, Cedars Sinai Medical Center, Los Angeles, California 90048, USA
    Obstet Gynecol 120:360-4. 2012
  5. doi request reprint Does risk-reducing bilateral salpingo-oophorectomy leave behind residual tube?
    Ilana Cass
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA
    Gynecol Oncol 117:27-31. 2010
  6. ncbi request reprint Allelotype of papillary serous peritoneal carcinomas
    I Cass
    Cedars Sinai Medical Center, Los Angeles, California, 90048, USA
    Gynecol Oncol 82:69-76. 2001
  7. ncbi request reprint BRCA-mutation-associated fallopian tube carcinoma: a distinct clinical phenotype?
    Ilana Cass
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of California Los Angeles, Cedars Sinai Medical Centers, CA 90048, USA
    Obstet Gynecol 106:1327-34. 2005
  8. ncbi request reprint BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study
    R L Baldwin
    Division of Gynecologic Oncology, The Burns and Allen Research Institute Cedars Sinai Medical Center, Los Angeles, California 90048 USA
    Cancer Res 60:5329-33. 2000
  9. ncbi request reprint Pattern of lymph node metastases in clinically unilateral stage I invasive epithelial ovarian carcinomas
    I Cass
    Cedars-Sinai Medical Center, Los Angeles, California 90048, USA
    Gynecol Oncol 80:56-61. 2001
  10. ncbi request reprint The prognostic significance of thrombocytosis in epithelial ovarian carcinoma
    Andrew J Li
    Department of Obstetrics and Gynecology, Cedars Sinai Medical Center, Geffen School of Medicine at UCLA, Los Angeles, CA 90048, USA
    Gynecol Oncol 92:211-4. 2004

Collaborators

Detail Information

Publications17

  1. ncbi request reprint Improved survival in women with BRCA-associated ovarian carcinoma
    Ilana Cass
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cedars Sinai Medical Center and University of California Los Angeles School of Medicine, Los Angeles, California 90048, USAA
    Cancer 97:2187-95. 2003
    ..The objective of this study was to determine the clinical characteristics, treatment response, and frequency of p53 overexpression in Ashkenazi Jewish women with hereditary ovarian carcinoma...
  2. ncbi request reprint Effect of obesity on survival in epithelial ovarian cancer
    James C Pavelka
    Cedars Sinai Medical Center, Women s Cancer Research Institute at the Samuel Oschin Comprehensive Cancer Institute, Los Angeles, California, USA
    Cancer 107:1520-4. 2006
    ..The current study attempted to determine the influence of excess body weight on ovarian cancer survival, disease progression, and clinicopathologic factors...
  3. ncbi request reprint Tertiary cytoreductive surgery in recurrent ovarian cancer: selection criteria and survival outcome
    Amer K Karam
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Cedars Sinai Medical Center, 8700 Beverly Blvd, Los Angeles, CA 90048, USA
    Gynecol Oncol 104:377-80. 2007
    ..We sought to evaluate the impact of TCS on survival and to determine predictors of optimal tertiary resection...
  4. ncbi request reprint Lessons learned in physician reentry
    Ilana Cass
    Department Obstetrics and Gynecology, Cedars Sinai Medical Center, Los Angeles, California 90048, USA
    Obstet Gynecol 120:360-4. 2012
    ..We no longer will accept a case log with cases drawn from other sites. We also will incorporate an assessment of each candidate's surgical skill using surgical simulation...
  5. doi request reprint Does risk-reducing bilateral salpingo-oophorectomy leave behind residual tube?
    Ilana Cass
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA
    Gynecol Oncol 117:27-31. 2010
    ..Risk-reducing bilateral salpingo-oophorectomy (RRSO) is an effective option for women with BRCA mutations however there is limited information as to how much tubal epithelium remains after RRSO...
  6. ncbi request reprint Allelotype of papillary serous peritoneal carcinomas
    I Cass
    Cedars Sinai Medical Center, Los Angeles, California, 90048, USA
    Gynecol Oncol 82:69-76. 2001
    ..The purpose of this study was to determine the incidence of allelic loss and the frequency of p53 mutation by p53 overexpression in PSPC compared to PSOC...
  7. ncbi request reprint BRCA-mutation-associated fallopian tube carcinoma: a distinct clinical phenotype?
    Ilana Cass
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of California Los Angeles, Cedars Sinai Medical Centers, CA 90048, USA
    Obstet Gynecol 106:1327-34. 2005
    ..To compare clinical and histologic features between fallopian tube cancers in women with germline BRCA mutations and sporadic cases...
  8. ncbi request reprint BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study
    R L Baldwin
    Division of Gynecologic Oncology, The Burns and Allen Research Institute Cedars Sinai Medical Center, Los Angeles, California 90048 USA
    Cancer Res 60:5329-33. 2000
    ....
  9. ncbi request reprint Pattern of lymph node metastases in clinically unilateral stage I invasive epithelial ovarian carcinomas
    I Cass
    Cedars-Sinai Medical Center, Los Angeles, California 90048, USA
    Gynecol Oncol 80:56-61. 2001
    ..Ipsilateral sampling may result in the understaging of patients. Bilateral pelvic and paraaortic LN sampling is recommended to accurately stage ovarian carcinoma...
  10. ncbi request reprint The prognostic significance of thrombocytosis in epithelial ovarian carcinoma
    Andrew J Li
    Department of Obstetrics and Gynecology, Cedars Sinai Medical Center, Geffen School of Medicine at UCLA, Los Angeles, CA 90048, USA
    Gynecol Oncol 92:211-4. 2004
    ..Thrombocytosis (platelet counts >400 x 10(9)/l) has been identified as a poor prognostic factor in many cancers. Platelet-secreted factors may contribute to metastasis, invasion, and primary tumor growth...
  11. ncbi request reprint Characterization of CSOC 882, a novel immortalized ovarian cancer cell line expressing EGFR, HER2, and activated AKT
    Daniel R Scoles
    Women s Cancer Research Institute at Samuel Oschin Comprehensive Cancer Institute and Division of Gynecologic Oncology, CSMC Burns and Allen Research Institute, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA
    Gynecol Oncol 104:120-8. 2007
    ..We describe a new ovarian cancer cell line that arose from primary culture of a stage IC, grade III ovarian carcinoma, designated CSOC 882...
  12. ncbi request reprint Coexisting ovarian malignancy in young women with endometrial cancer
    Christine Walsh
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, UCLA and Cedars Sinai Medical Centers, Los Angeles, California 90048, USA
    Obstet Gynecol 106:693-9. 2005
    ..In premenopausal women with endometrial cancer, ovarian preservation may be a consideration. Our objective was to examine the occurrence of coexisting ovarian malignancy and to identify predictors of adnexal involvement...
  13. doi request reprint Hormone receptor expression in uterine sarcomas: prognostic and therapeutic roles
    Y J Ioffe
    Department of Obstetrics and Gynecology, Cedars Sinai Medical Center, Los Angeles, CA, USA
    Gynecol Oncol 115:466-71. 2009
    ..Conducting immunohistochemical staining to ascertain ER status may aid with prognostication in this disease. Hormone therapy should be considered in patients with primary and recurrent ER-positive uterine sarcomas...
  14. ncbi request reprint The prognostic significance of thrombocytosis in uterine papillary serous carcinomas
    Dimitry L Lerner
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Cedars Sinai Medical Center, 8700 Beverly Blvd, Suite 160W, Los Angeles, CA 90048, USA
    Gynecol Oncol 104:91-4. 2007
    ..In light of the similarities between uterine papillary serous carcinomas (UPSC) and EOC, we sought to determine the incidence of thrombocytosis in UPSC and examine associations with clinico-pathologic features and survival...
  15. ncbi request reprint Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer
    Allison E Axtell
    University of California Los Angeles UCLA Medical Center, Los Angeles, CA, USA
    J Clin Oncol 25:384-9. 2007
    ..Reciprocally cross validate the predictors identified with those from two previously published cohorts from institutions B and C...
  16. ncbi request reprint Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions
    Johnathan M Lancaster
    H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA
    Gynecol Oncol 107:159-62. 2007
    ..This commentary provides guidance on identification of patients who may benefit from hereditary cancer risk assessment for Hereditary Breast/Ovarian Cancer and the Lynch/Hereditary Non-Polyposis Colorectal Cancer syndrome...
  17. ncbi request reprint Secondary cytoreductive surgery for isolated nodal recurrence in patients with epithelial ovarian cancer
    Antonio Santillan
    The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, 600 N Wolfe Street, Phipps 281, Baltimore, MD 21287 1281, USA
    Gynecol Oncol 104:686-90. 2007
    ..To evaluate the feasibility and associated survival outcome of secondary cytoreductive surgery in patients with isolated lymph node recurrence of epithelial ovarian cancer...